Chia Seeds
8 benefits mapped to clinical evidence across supplements.
Dose per serving from research
8 study groups in 6 studies say how much Chia Seeds participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 25 g to 50 g, 63% of 8 study groups.
| Daily dose | Study groups |
|---|---|
| 10 g to 25 g | 2 |
| 25 g to 50 g | 5 |
| 50 g to 100 g | 1 |
Benefit Evidence
Research sources
Heart health (3)
- Chia seed (Salvia hispanica L.) supplementation to the diet of adults with type 2 diabetes improved systolic blood pressure: A randomized controlled trial
PubMed ID: 33530854
40 g/day chia for 12 weeks lowered systolic BP in adults with T2DM (small trial but BP change supports heart benefit).
- Effect of a dietary intervention with functional foods on LDL-C concentrations and lipoprotein subclasses in overweight subjects with hypercholesterolemia: Results of a controlled trial
PubMed ID: 33932799
A multi-food diet that included chia reduced LDL-C and total cholesterol and improved lipoprotein profile; chia-specific effect uncertain.
- Effect of chia seeds or concentrated fish oil on cardiometabolic risk markers in subjects with hypertriglyceridaemia: a parallel clinical trial
PubMed ID: 39360590
30 g/day chia in high-TG patients substantially lowered triglycerides and reduced DBP, cardiometabolic improvements relevant to heart health.
Metabolism (2)
- Effect of chia seeds or concentrated fish oil on cardiometabolic risk markers in subjects with hypertriglyceridaemia: a parallel clinical trial
PubMed ID: 39360590
In hypertriglyceridaemia, 30 g/day chia produced large TG reductions and DBP drop, indicating metabolic benefit.
- Salba-chia (Salvia hispanica L.) in the treatment of overweight and obese patients with type 2 diabetes: A double-blind randomized controlled trial
PubMed ID: 28089080
Salba-chia added to calorie restriction produced greater weight and waist loss and lowered CRP in T2DM, implying metabolic improvement (co-intervention).
Nutrition source (2)
- Chia seed supplementation and disease risk factors in overweight women: a metabolomics investigation
PubMed ID: 22830971
Milled chia increased plasma ALA (+58%) and EPA (+39%), strong evidence of plant omegaβ3 conversion/biomarker rise.
- Chia seed does not promote weight loss or alter disease risk factors in overweight adults
PubMed ID: 19628108
50 g/day chia raised plasma ALA (+24.4%), indicating an omegaβ3 nutrient increase.
Cholesterol (2)
- Effect of chia seeds or concentrated fish oil on cardiometabolic risk markers in subjects with hypertriglyceridaemia: a parallel clinical trial
PubMed ID: 39360590
In high-TG patients, chia substantially reduced triglycerides (important lipid risk factor) and improved DBP; TG change is a favorable lipid effect.
- Effect of a dietary intervention with functional foods on LDL-C concentrations and lipoprotein subclasses in overweight subjects with hypercholesterolemia: Results of a controlled trial
PubMed ID: 33932799
Dietary portfolio including chia produced clinically meaningful LDL-C and total cholesterol reductions and improved lipoprotein subclasses (multi-food intervention).
Inflammation (2)
- Salba-chia (Salvia hispanica L.) in the treatment of overweight and obese patients with type 2 diabetes: A double-blind randomized controlled trial
PubMed ID: 28089080
Salba-chia with calorie restriction reduced CRP significantly in T2DM patients, indicating anti-inflammatory effect (in context of diet).
- Assessing the Metabolic Impact of Ground Chia Seed in Overweight and Obese Prepubescent Children: Results of a Double-Blind Randomized Clinical Trial
PubMed ID: 31928474
Obese children's trial showed reductions in fibrinogen and TNF-Ξ± associated with chia/fiber supplementation.
Blood sugar (1)
- Co-administration of viscous fiber, Salba-chia and ginseng on glycemic management in type 2 diabetes: a double-blind randomized controlled trial
PubMed ID: 33486572
Multi-ingredient supplement containing Salba-chia produced a modest HbA1c improvement in treated T2DM patients (cannot isolate chia effect).
Weight management (1)
- Salba-chia (Salvia hispanica L.) in the treatment of overweight and obese patients with type 2 diabetes: A double-blind randomized controlled trial
PubMed ID: 28089080
Adding Salba-chia to a calorie-restricted diet produced greater weight loss and waist reduction vs control in people with T2DM.
Immune support (1)
- Assessing the Metabolic Impact of Ground Chia Seed in Overweight and Obese Prepubescent Children: Results of a Double-Blind Randomized Clinical Trial
PubMed ID: 31928474
Trial in obese children found reductions in TNF-Ξ± and fibrinogen (inflammatory/immune-related markers), suggesting immune/inflammatory modulation.
Similar by evidence
Supplements the same benefits carry qualifying findings for β a fact about the evidence graph, not a recommendation to swap.
Products with Chia Seeds
Search all84 products whose verified label declares Chia Seeds β not every bottle that mentions it in a title.
Being studied right now
Recruiting clinical trials registered on ClinicalTrials.gov. A trial in progress has no result yet β this is what the field is asking, not what it found.